{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T23:04:30Z","timestamp":1792623870488,"version":"4.5.0"},"reference-count":9,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2005,9,12]],"date-time":"2005-09-12T00:00:00Z","timestamp":1126483200000},"content-version":"vor","delay-in-days":11,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J of Cosmetic Dermatology"],"published-print":{"date-parts":[[2005,9]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Idebenone is an antioxidant lower molecular weight analogue of coenzyme Q10. Previously, idebenone was shown to be a very effective antioxidant in its ability to protect against cell damage from oxidative stress in a variety of biochemical, cell biological, and <jats:italic>in vivo<\/jats:italic> methods, including its ability to suppress sunburn cell (SBC) formation in living skin. However, no clinical studies have been previously conducted to establish the efficacy of idebenone in a topical skincare formulation for the treatment of photodamaged skin. In this nonvehicle control study, 0.5% and 1.0% idebenone commercial formulations were evaluated in a clinical trial for topical safety and efficacy in photodamaged skin. Forty\u2010one female subjects, aged 30\u201365, with moderate photodamaged skin were randomized to use a blind labelled (either 0.5% or 1.0% idebenone in otherwise identical lotion bases) skincare preparation twice daily for six weeks. Blinded expert grader assessments for skin roughness\/dryness, fine lines\/wrinkles, and global improvement in photodamage were performed at baseline, three weeks and six weeks. Electrical conductance readings for skin surface hydration and 35\u00a0mm digital photography were made at baseline after six weeks. Punch biopsies were taken from randomly selected subjects, baseline and after six weeks, and stained for certain antibodies (interleukin IL\u20106, interleukin IL\u20101b, matrixmetalloproteinase MMP\u20101, collagen I) using immunofluorescence microscopy. After six weeks\u2019 use of the 1.0% idebenone formula, a 26% reduction in skin roughness\/dryness was observed, a 37% increase in skin hydration, a 29% reduction in fine lines\/wrinkles, and a 33% improvement in overall global assessment of photodamaged skin. For the 0.5% idebenone formulation, a 23% reduction in skin roughness\/dryness was observed, a 37% increase in skin hydration, a 27% reduction in fine lines\/wrinkles, and a 30% improvement in overall global assessment of photodamaged skin. The immunofluorescence staining revealed a decrease in IL\u20101b, IL\u20106, and MMP\u20101 and an increase in collagen I for both concentrations.<\/jats:p>","DOI":"10.1111\/j.1473-2165.2005.00305.x","type":"journal-article","created":{"date-parts":[[2005,9,12]],"date-time":"2005-09-12T10:11:24Z","timestamp":1126519884000},"page":"167-173","source":"Crossref","is-referenced-by-count":46,"title":["Clinical efficacy assessment in photodamaged skin of 0.5% and 1.0% idebenone"],"prefix":"10.1111","volume":"4","author":[{"given":"DH","family":"McDaniel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BA","family":"Neudecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JC","family":"DiNardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"II","given":"JA","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HI","family":"Maibach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,9,12]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"59","article-title":"Cosmeceuticals: a review of the science behind the claims","volume":"16","author":"Farris PK","year":"2003","journal-title":"Cosmet Derm"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1524-4725.2002.01129.x"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.125.10.1091"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/biof.5520090238"},{"key":"e_1_2_6_6_2","first-page":"55","article-title":"Anti\u2010aging benefits of topical formulation containing Coenzyme Q10: Results of 2 clinical studies","volume":"15","author":"Ghosk DK","year":"2002","journal-title":"Cosmet Dermatol"},{"key":"e_1_2_6_7_2","doi-asserted-by":"crossref","unstructured":"McDanielDH NeudeckerBA DiNardoJC LewisIIJA MaibachHI.Idebenone: a new antioxidant \u2013 Part I. Relative assessment of oxidative stress protection capacity compared to commonly known antioxidants.J Cosmet Dermatol2005;4:10\u20137.","DOI":"10.1111\/j.1473-2165.2005.00152.x"},{"key":"e_1_2_6_8_2","unstructured":"SouthJ.Idebenone: the ultimate antiaging drug.Offshore Pharmacy March 1997."},{"key":"e_1_2_6_9_2","unstructured":"McDanielDH.Genetic research unlocks secrets of effective skincare.Aesthetic Buyers Guide January\/February 2004."},{"key":"e_1_2_6_10_2","unstructured":"http:\/\/public.bcm.tmc.edu\/rosenlab\/protocols\/generalIF.pdf."}],"container-title":["Journal of Cosmetic Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1473-2165.2005.00305.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1473-2165.2005.00305.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T22:23:36Z","timestamp":1696976616000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1473-2165.2005.00305.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":9,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["10.1111\/j.1473-2165.2005.00305.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1473-2165.2005.00305.x","archive":["Portico"],"relation":{},"ISSN":["1473-2130","1473-2165"],"issn-type":[{"value":"1473-2130","type":"print"},{"value":"1473-2165","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,9]]}}}